Resolving differential vascular graft remodeling using longitudinal multiphoton tracking in a 3D culture platform

This study introduces a 3D organotypic artery-graft culture platform that enables non-destructive, longitudinal multiphoton imaging of tissue remodeling, successfully correlating short-term in vitro responses to specific TGF-beta isoforms and graft designs with long-term in vivo outcomes to facilitate the pre-clinical optimization of vascular grafts.

The Gist

Imagine you are trying to build a tiny, artificial replacement for a human blood vessel. This is a huge challenge in medicine, especially for small vessels where current replacements often fail, getting clogged or scarred over time.

The problem is that scientists usually have to wait months or years, implant these artificial vessels into animals, and then cut them open at the very end to see if they worked. It's like baking a cake, waiting six months for it to rise, and then only then cutting it open to see if the inside is good. By then, it's too late to fix the recipe.

This paper introduces a new "time-travel" kitchen that lets scientists watch the cake rise in real-time, without ever taking it out of the oven.

The Problem: The "Black Box" of Vessel Repair

When a tissue-engineered graft (the artificial vessel) is placed next to a real artery, a magical process called remodeling happens. The body's cells move in, and they start building new collagen (a strong protein fiber) to stitch the graft to the body.

• The Old Way: Scientists put the graft in an animal, wait 6 months, and then kill the animal to look at the result. They don't know how it got there, only where it ended up.
• The Gap: There was no way to watch this process happen day-by-day in a 3D shape that looks like a real tube.

The Solution: The "Floating Tube" Lab

The researchers built a special, modular culture system. Think of it like a suspension bridge for tiny tubes.

1. The Setup: They took a small piece of a rat's real artery and a small piece of their artificial graft.
2. The Bridge: Instead of gluing them together (which would mess up the experiment), they placed them on a tiny, floating metal rod (a mandrel) held up by 3D-printed hexagon stands. This keeps the tube shape perfect and lets the two pieces touch naturally, just like in a real surgery.
3. The Magic Glasses: They didn't use dyes or stains that kill the cells. Instead, they used a special microscope (multiphoton imaging) that acts like X-ray specs.
   • Seeing the Cells: The microscope sees the natural glow of living cells (like seeing fireflies in the dark).
   • Seeing the Structure: It also sees the collagen fibers as they are built, glowing with a different color (Second Harmonic Generation).

What They Discovered

1. Watching the Construction Crew
Using these "magic glasses," they watched the cells move onto the artificial tube over 8 weeks. They saw the cells arrive, and then they saw the collagen fibers slowly weave together, turning the artificial tube into something that looks and acts like a real blood vessel. It was like watching a construction crew build a bridge in fast-forward.

2. The "Crystal Ball" Effect
The most exciting part? They compared their 8-week "time-lapse" video to actual grafts that had been inside rats for 6 months.

• The Result: The patterns they saw in the lab (how the fibers lined up, how thick they were) matched the 6-month results almost perfectly.
• The Analogy: It's like looking at a sapling in a greenhouse and being able to predict exactly how the oak tree will look 20 years later. This means scientists can now test graft designs in a few weeks instead of waiting years.

3. Testing the "Ingredients"
They also tested what happens if you add different "flavors" of growth signals (specifically TGF-β proteins).

• The Finding: Different proteins made the collagen fibers grow in different shapes. One made them thin and wispy; another made them thick and strong.
• Why it matters: This proves the system is sensitive enough to detect subtle changes. If a new material or drug changes how the vessel heals, this lab setup will catch it immediately.

Why This Changes Everything

Before this, testing a new artificial vessel was a slow, expensive, and destructive process. You had to guess, build, implant, wait, and hope.

Now, this platform acts as a high-tech filter.

• Fast: You get answers in weeks, not years.
• Cheap: You don't need hundreds of animals.
• Safe: You can see why a graft fails before you ever put it in a patient.

In short: This paper gives scientists a window into the future of vascular repair. It turns the mysterious, slow process of healing into a visible, controllable, and fast-forwardable event, helping us design better, safer artificial blood vessels for humans.

Technical Summary

1. The Problem

The development of small-diameter tissue-engineered vascular grafts (TEVGs) faces a significant translational bottleneck. While TEVGs show promise, their clinical success depends on early remodeling events at the tissue-graft interface (cellularization and extracellular matrix organization). However, current evaluation methods have critical limitations:

• In Vivo Studies: Animal implantation studies are resource-intensive, low-throughput, and rely heavily on destructive endpoint analyses or macroscale monitoring, making it difficult to resolve longitudinal microstructural changes non-invasively.
• In Vitro Models: Existing 2D monolayer cultures fail to recapitulate the 3D cylindrical geometry and microenvironment of blood vessels. While 3D bioreactors exist, they are often low-throughput, expensive, and require destructive endpoint assays to assess integration.
• The Gap: There is a lack of an accessible, intermediate model that preserves the cylindrical artery-graft geometry while enabling non-destructive, longitudinal, high-resolution monitoring of remodeling trajectories before committing to animal studies.

2. Methodology

The authors developed a novel organotypic 3D artery-graft culture platform coupled with label-free multiphoton microscopy.

• Platform Design:

  • Geometry: Rat abdominal aortic explants (~5 mm) are coupled with acellular TEVG segments on PTFE-coated stainless-steel mandrels.
  • Support System: 3D-printed polycarbonate hexagonal holders elevate the constructs above the culture media surface, allowing access for upright or inverted imaging.
  • Configurations: The modular system supports single-interface (artery-to-graft), interpositional (double-interface), and autologous graft (rejoined aorta) models.
  • Culture Conditions: Static culture in Smooth Muscle Cell Growth Medium (SmGM-2) without imposed hemodynamic flow or axial loading, mimicking the "aortic ring assay" but with graft integration.

• Imaging & Analysis:

  • Multiphoton Microscopy: Utilized Second Harmonic Generation (SHG) to visualize fibrillar collagen and Two-Photon Excited Fluorescence (2PEF) to track cellularization and scaffold autofluorescence.
  • Label-Free: The system relies on endogenous signals, avoiding the need for exogenous dyes that might interfere with remodeling.
  • Quantification: SHG images were processed using the CT-FIRE pipeline to quantify collagen fiber metrics (width, length, straightness, and orientation).
  • Validation: Results were cross-validated with histology (Picrosirius red), immunostaining (vimentin, $\alpha$-SMA), and qRT-PCR.

• Graft Materials:

  • Primary focus on a compliance-matched trilayered TEVG (PEUU/Gelatin blend with a hemocompatible PESBUU-50 inner layer).
  • Secondary validation with electrospun PESBUU-50 and other biomaterials (PCL, UBM-hydrogel).

3. Key Contributions

• Geometry-Preserving Ex Vivo Model: A low-cost, high-throughput platform that maintains the cylindrical anastomotic geometry of vascular grafts without sutures or adhesives, isolating remodeling outcomes attributable to tissue-graft apposition.
• Longitudinal, Non-Destructive Imaging: Demonstrated the ability to track the same construct over 8 weeks, resolving the temporal evolution of collagen deposition and cellular infiltration without sacrificing the sample.
• Predictive Correlation: Showed that 8-week culture-derived remodeling phenotypes and collagen microarchitectures strongly correlate with 6-month in vivo implantation outcomes in rats.
• Biochemical Sensitivity: Proved the platform's ability to detect subtle differences in remodeling induced by specific biochemical cues (TGF-$\beta$ isoforms).

4. Key Results

• Longitudinal Imaging Feasibility:

  • SHG (Collagen): Fibrillar collagen (SHG signal) was undetectable initially but progressively accumulated over 8 weeks, evolving from short, thin microfibers to longer, thicker strands resembling mature tissue.
  • 2PEF (Cells): Endogenous 2PEF signals appeared early, corresponding to cellular structures. Validation with DAPI and Hoechst confirmed these signals represented nucleated cells infiltrating the graft.
  • Compatibility: The platform worked with multiple biomaterial classes (PEUU, PCL, Gelatin) and species (rat and mouse, including fluorescent reporter mice).

• Correlation with In Vivo Outcomes:

  • Trilayered TEVGs: The collagen fiber architecture (length, width, straightness, orientation) observed in 8-week cultures closely matched that of 6-month in vivo explants. While in vivo grafts had higher total collagen volume, the trajectories and microstructural distributions were highly similar.
  • PESBUU-50 TEVGs: Both culture and in vivo models showed minimal SHG deposition, confirming the platform could also predict grafts with poor remodeling potential.

• Response to TGF-$\beta$ Isoforms:

  • Treatment with TGF-$\beta$1, -$\beta$2, and -$\beta$3 (10 ng/mL) induced distinct remodeling responses compared to vehicle controls.
  • Microstructural Shifts: TGF-$\beta$2 induced narrower collagen fibers compared to -$\beta$1 and -$\beta$3.
  • Gene Expression: These structural changes were accompanied by significant shifts in the expression of contractile (Myh11, Acta2) and matrix-remodeling (Lox, Col1a1, Col3a1) genes, validating that the imaging readouts reflect true biological changes.

5. Significance

This work establishes a practical intermediate screening platform that bridges the gap between simplified 2D cell cultures and resource-intensive animal studies.

• De-risking Graft Design: Researchers can now longitudinally assess remodeling trajectories and prioritize graft designs before committing to expensive and time-consuming animal implantation studies.
• Mechanistic Insight: The platform allows for the dissection of specific biochemical and material drivers of remodeling (e.g., isoform-specific TGF-$\beta$ effects) at the microstructural level, which is difficult to achieve in whole-animal models.
• Accessibility: By utilizing standard cultureware and avoiding complex bioreactors, the system lowers the barrier to entry for vascular tissue engineering research while providing high-resolution, quantitative data.
• Future Impact: The ability to track remodeling non-destructively enables the study of dynamic processes leading to graft failure (stenosis) or success (integration), potentially accelerating the translation of durable small-diameter vascular grafts.